RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 75mg film coated tablet blister pack

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

risedronate sodium hemipentahydrate, Quantity: 86.7 mg

Fáanlegur frá:

GM Pharma International Pty Ltd

INN (Alþjóðlegt nafn):

Risedronate sodium hemipentahydrate

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: crospovidone; colloidal anhydrous silica; titanium dioxide; iron oxide red; magnesium stearate; hyprolose; macrogol 8000; hypromellose; lactose

Stjórnsýsluleið:

Oral

Einingar í pakka:

4, 8, 2, 6

Tegund:

Medicine Registered

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

The treatment of osteoporosis,The treatment of glucocorticoid-induced osteoporosis,The preservation of bone-mineral density in patients on long term corticosteroid therapy

Vörulýsing:

Visual Identification: Dark pink, round, biconvex coated tablet. Engraved "APO" on one side, "RIS" over "75" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2012-03-08